From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...
January is National Radon Action Month, and the American Lung Association is raising awareness of the potential health risks of radon and the importance of home testing. Exposure to radon is the ...
Edgardo S. Santos, MD, FACP, FASCO, emphasized the need to eliminate the stigma around smoking in lung cancer, highlighted the importance of early detection and discussed how advances in precision ...
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today ...
The new Phase III study will test calderasib in a chemo-free regimen for G12C-mutated patients regardless of PD-L1 status.
With a San Antonio biotech firm’s test, your phlegm could help save you from cancer. The screening method developed by bioAffinity Technologies Inc. uses AI-aided computer analysis of a patient’s ...
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer and lung ...
The FDA approved the Oncomine Dx Express Test for rapid identification of NSCLC patients eligible for Zegfrovy treatment. The test provides results in 24 hours, aiding timely therapeutic decisions and ...
Use of a deep learning model on H&E slides to predict nucleic acid yield for NGS testing. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not include a full ...
People with lung cancer will be offered a new blood test designed to speed up access to targeted treatments and avoid unnecessary biopsies, officials have announced. About 15,000 patients a year are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback